A Single Dose of a Marketed Drug Being Studied for a New Indication to Treat Surgical Site Infection Following Colorectal Surgery as Compared to a Marketed Drug Approved for This Indication (0826-039)

Clinical trial NCT00090272 · COMPLETED

Trial details

NCT number: NCT00090272
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Colorectal Surgery

Start date: 2002-04-01
Primary completion: 2005-03-01
Enrollment: 952

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.